Post

New research · Ophthalmology
Translational vision science & technology · 12h
Cross-sectionalTranslational vision science & technology · 2026

OptiDON-Guard: An Ensemble Model for Identification of Dysthyroid Optic Neuropathy Using Optical Coherence Tomography Angiography.

Yanchen Zhang, Yicheng Mao, Jianming Zheng … Wentao Yan
Read paper
OphthalmologyCross-sectional

Optical coherence tomography angiography-based AI model identifies dysthyroid optic neuropathy with 0.854 AUC on external testing

OptiDON-Guard: An Ensemble Model for Identification of Dysthyroid Optic Neuropathy Using Optical Coherence Tomography Angiography.

Yanchen Zhang … Wentao Yan
Translational vision science & technology · 2026
Purpose

To explore the value of machine learning models based on optical coherence tomography angiography (optical coherence tomography angiography) in identifying dysthyroid optic neuropathy (dysthyroid optic neuropathy).

Methods

Underwent ophthalmic examinations, including optical coherence tomography angiography scans centered on the macula and optic nerve head.

n = 346 thyroid eye disease patients
Results

AUC scale: 1.0 is perfect discrimination; 0.854 shows strong accuracy on outside data

0.872AUC
Internal validation
0.854AUC
External test
More results

The ensemble model, OptiDON-Guard, demonstrated superior performance to individual models on both internal validation and external test sets.

In the internal validation set, it achieved an AUC of 0.872, accuracy of 0.943, sensitivity of 0.667, specificity of 0.979, and precision of 0.943.

“
Conclusion

The OptiDON-Guard is a reliable, interpretable, and clinically applicable tool for identifying dysthyroid optic neuropathy.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving